Overview
Top Medical Research Studies
The results indicated that those treated with Lactobacillus experienced a notable reduction in the duration and frequency of diarrhea compared to those given a placebo. With a safe profile at high doses, this probiotic shows promise as a simple, low-risk solution to alleviate diarrhea in young patients.
These children also showed better gut microbiome changes. Specifically, more of them reported improvement compared to the placebo group. Overall, LRa05 proved to be a promising treatment option for easing diarrhea in children.
In a controlled setting, we administered LGG or a placebo to eligible patients and monitored diarrhea symptoms. While the data suggested a reduction in AAD occurrence, with 30% in the LGG group compared to 55.5% in the placebo group, the difference wasn't statistically significant.
Nevertheless, LGG proved safe for pediatric patients, encouraging us to think positively about its future use in similar cases.
Most Useful Reviews
Medical Researches
- All Researches
Supplementation was particularly effective when paired with standard triple therapy, showing promising results, especially in children. This positions Lactobacillus as a valuable adjunct treatment option for managing these infections while reducing discomfort.
Using samples from 28 IBS patients and 7 healthy controls, we examined how this probiotic affects the intestinal barrier.
The results were promising: Serobioma significantly strengthened the intestinal lining and countered permeability changes caused by IBS-related substances. This was especially true for IBS patients who primarily experienced diarrhea, suggesting that probiotics could be a useful addition to their treatment plans.
Treatment with TCT led to less inflammation, indicated by lower levels of IL-6 and TNF-α, and improved colon tissue structure. Notably, TCT increased beneficial bacteria like Lactobacillus. This study highlights a promising approach to managing AAD through natural compounds.
The results indicated that those treated with Lactobacillus experienced a notable reduction in the duration and frequency of diarrhea compared to those given a placebo. With a safe profile at high doses, this probiotic shows promise as a simple, low-risk solution to alleviate diarrhea in young patients.
This impressive outcome suggests that LP not only strengthens gut health but also helps combat harmful bacteria. Our findings indicate that LP could be a safe and eco-friendly option for improving poultry health and productivity.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Diarrhea is a condition characterized by the frequent passage of loose or watery stools, which can occur due to various factors, including infections, dietary choices, and underlying health conditions. It often results from the body's response to an irritation of the gastrointestinal tract, which can be caused by viruses, bacteria, parasites, or certain medications. While most cases tend to be short-lived and resolve on their own, diarrhea can lead to dehydration, especially in vulnerable populations such as young children and the elderly.
Managing diarrhea typically involves staying hydrated by drinking clear fluids and, when necessary, replenishing lost electrolytes. In some cases, over-the-counter medications may provide relief, although it’s essential to consult a healthcare professional for persistent or severe symptoms. A focus on bland, easy-to-digest foods can also help during recovery. Remember, if diarrhea persists for more than a couple of days or is accompanied by other concerning symptoms—like high fever, severe abdominal pain, or blood in stools—seeking medical attention is crucial.
Lactobacillus is a genus of bacteria that plays a crucial role in the fermentation of various foods and is found naturally in the human gut. Known for their probiotic properties, strains of Lactobacillus are commonly utilized in the production of yogurt, sauerkraut, and other fermented products. They are characterized by their rod-shaped structure and ability to convert sugars into lactic acid, which not only helps preserve food but also contributes to the tangy flavor of fermented foods.
In addition to their culinary uses, Lactobacillus bacteria can offer several health benefits. They are known to support gut health by enhancing the balance of beneficial bacteria in the microbiome, potentially aiding in digestion and alleviating symptoms of issues like irritable bowel syndrome (IBS). Regular consumption of Lactobacillus-containing foods or supplements may also bolster the immune system and improve overall digestive health. With a growing interest in gut health, Lactobacillus remains a key player in both dietary and therapeutic contexts.
Lactobacillus, a type of beneficial bacteria found in probiotics, has been studied for its potential role in alleviating diarrhea. Research indicates that certain strains of Lactobacillus can effectively help manage and reduce the duration of diarrhea, particularly in cases related to antibiotic use or viral infections. The probiotics work by restoring the natural balance of gut flora, which may be disrupted during bouts of diarrhea. By promoting a healthier gut environment, Lactobacillus can enhance the body's natural defenses against pathogens and improve overall digestive health.
When considering Lactobacillus for diarrhea management, it's essential to select products that contain specific strains known for their efficacy. Look for probiotics labeled with the genus and species, such as Lactobacillus rhamnosus GG or Lactobacillus reuteri, which have shown promise in clinical studies. Additionally, while Lactobacillus can be beneficial, it is advisable to consult with a healthcare professional, particularly if diarrhea is severe or persists beyond a couple of days. They can provide guidance tailored to your situation and help determine the best course of treatment.
The time it takes to see results from taking Lactobacillus for diarrhea can vary based on several factors, including the severity of the condition, the specific strain of Lactobacillus used, and an individual's overall health. Generally, many users report noticing improvements within 24 to 72 hours after starting a probiotic regimen. However, in some cases, it may take a week or more for the beneficial effects to manifest. It's important to be consistent with the dosage and to combine it with other healthy lifestyle choices, such as staying hydrated and consuming a balanced diet, for optimal results.
As with any supplement, individual responses can differ. Factors such as the underlying cause of diarrhea, whether it's due to antibiotics, stress, or infections, will also play a role in how quickly Lactobacillus can help. Consulting a healthcare professional is advisable if symptoms persist beyond a few days, to rule out any serious conditions and to get personalized recommendations on the best approach to recovery.
This supplement appears to be well-supported by scientific research for its role in managing diarrhea, primarily through the use of probiotic strains like Lactobacillus. For instance, a study demonstrated that Lactobacillus reuteri DSM 17938, when added to oral rehydration therapy, significantly reduced the duration and frequency of diarrhea in children suffering from acute gastroenteritis [5]. Similarly, Lactobacillus rhamnosus has shown promise in alleviating symptoms associated with both antibiotic-associated diarrhea (AAD) and irritable bowel syndrome (IBS), making it a valuable option for various types of diarrheal issues [28], [2].
Moreover, a comparison of different probiotic interventions has indicated that Lactobacillus strains successfully help reduce diarrhea in young children and those undergoing antibiotic treatments [18]. They also demonstrate effectiveness in improving gut health, enhancing beneficial bacteria, and reducing inflammation related to intestinal disturbances [11], [20]. These findings solidify the role of Lactobacillus-based supplements as a potential therapeutic avenue for managing diarrhea.
The recommended dose of Lactobacillus for treating diarrhea typically ranges from 5 billion to 10 billion colony-forming units (CFUs) per day. This dosage has been found effective in various studies, particularly in cases of antibiotic-associated diarrhea and viral gastroenteritis in children. However, it's important to note that the specific strain of Lactobacillus can influence efficacy, so it's beneficial to choose a product that is well-studied for your particular condition. Always consult with a healthcare professional before starting any new probiotic regimen, especially for children or individuals with underlying health conditions.
When it comes to using Lactobacillus for treating diarrhea, the research highlights that a high-dose regimen can significantly benefit young patients. Specifically, a study focused on Lactobacillus reuteri DSM 17938 indicated that children further benefited from supplementation alongside oral rehydration therapy, experiencing a notable reduction in the duration and frequency of diarrhea episodes compared to placebo recipients [5]. This suggests that a targeted therapeutic approach with Lactobacillus can serve as an effective and low-risk solution for alleviating diarrhea, especially in pediatric cases.
Moreover, other studies emphasizing Lactobacillus rhamnosus revealed that it effectively reduced diarrhea severity and abdominal pain, particularly in children suffering from conditions like irritable bowel syndrome and antibiotic-associated diarrhea [28]. While the optimal dose may vary depending on individual factors and the specific formulation, these findings indicate that utilizing high doses of Lactobacillus in clinical practice holds considerable promise for managing diarrhea across various populations, particularly in younger children.
The results indicated that those treated with Lactobacillus experienced a notable reduction in the duration and frequency of diarrhea compared to those given a placebo. With a safe profile at high doses, this probiotic shows promise as a simple, low-risk solution to alleviate diarrhea in young patients.
In our study of 54 patients, we noted significant reductions in diarrhea severity and abdominal pain after 21 days of daily probiotic intake. For those with IBS, symptoms decreased nearly threefold, while AAD patients saw even greater improvements.
Additionally, microbiological analysis confirmed that the probiotic improved gut health by increasing beneficial bacteria. Overall, we found Neobiotic Lactobalance® effective in normalizing gut flora and alleviating diarrhea symptoms.
Using samples from 28 IBS patients and 7 healthy controls, we examined how this probiotic affects the intestinal barrier.
The results were promising: Serobioma significantly strengthened the intestinal lining and countered permeability changes caused by IBS-related substances. This was especially true for IBS patients who primarily experienced diarrhea, suggesting that probiotics could be a useful addition to their treatment plans.
Our findings revealed that probiotics significantly lowered both the incidence and duration of AAD compared to the placebo group. Patients reported positive outcomes, indicating high adherence to the treatment as well.
References
- Mei LN, Wang ZJ, Duan Y, Shen JS, Ye HB, et al. 4-Hydroxyboesenbergin B of Alpinia japonica protected gastrointestinal tract by inhibiting vancomycin-resistant enterococcus and balancing intestinal microbiota. J Ethnopharmacol. 2025;347:119737. doi:10.1016/j.jep.2025.119737
- Barbaro MR, Bianco F, Cremon C, Marasco G, Stanghellini V, et al. A Probiotic Mixture of LR 32, BL 04, and BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1. Int J Mol Sci. 2025;26. doi:10.3390/ijms26062656
- Fan D, Jiao S, Fu Y, Zhang J, Zhuang Y, et al. improves intestinal microbiota and barrier function to alleviate diarrhea of neonatal goats. Anim Nutr. 2025;20:366. doi:10.1016/j.aninu.2024.10.008
- Xu H, Zhang F, Huang Y, Yao Q, Guan Y, et al. [ Turcz. alleviates antibiotic-associated diarrhea in mice by modulating gut microbiota structure and regulating the EGFR/PI3K/Akt signaling pathway]. Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:285. doi:10.12122/j.issn.1673-4254.2025.02.09
- Iramain R, Jara A, Ortiz J, Cardozo L, Morinigo R. Lactobacillus reuteri protectis DSM 17938 at high doses versus placebo in children with acute gastroenteritis in a Pediatric Emergency Department. J Pediatr Gastroenterol Nutr. 2025. doi:10.1002/jpn3.70026
- Wang Z, Zhao Y, Fan D, Zhang J, Diao Q, et al. Sheep-Derived M5 Enhances Immunity and Antioxidant Capacity, Alleviates Diarrhea, and Improves Intestinal Health in Early-Weaned Lambs. Microorganisms. 2025;13. doi:10.3390/microorganisms13020404
- Zhao Y, Liang S, Fu X, Guo Y, Wang Y, et al. Anti-Inflammatory and Antidiarrheal Effects of Two Strains of Lactic Acid Bacteria Isolated from Healthy Pets on K88-Induced Diarrhea in Mice. Microorganisms. 2025;13. doi:10.3390/microorganisms13020239
- Chung A, Sehgal M, Gavrilita C, Falkos S, Vidal R. in the Prevention of Antibiotic-Associated Diarrhea in the Pediatric Intensive Care Unit: A Prospective Randomized, Double-Blind Placebo Controlled Intervention. J Pediatr Pharmacol Ther. 2025;30:47. doi:10.5863/1551-6776-30.1.47
- Hai PV, Phuong HTA, Hung PHS, Na TT, Lai NH, et al. Selection of Lactobacillus strains from native chicken feces for the fermentation of purple onion ( L.) as an antibiotic alternative against spp. in chickens. Open Vet J. 2024;14:3525. doi:10.5455/OVJ.2024.v14.i12.35
- Lin Z, Feng Y, Wang J, Men Z, Ma X. Microbiota governs host chenodeoxycholic acid glucuronidation to ameliorate bile acid disorder induced diarrhea. Microbiome. 2025;13:36. doi:10.1186/s40168-024-02011-8
- Wei JJ, Zhang PH, Yang ZY, Liu LP, Lian TT, et al. Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial. Surg Endosc. 2025;39:1893. doi:10.1007/s00464-025-11542-6
- Mishra V, Dash D, Panda AK, Pathak SK. Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis. Helicobacter. 2024;29:e70006. doi:10.1111/hel.70006
- Li S, Lu T, Lin Z, Zhang Y, Zhou X, et al. Supplementation with probiotics co-cultivation improves the reproductive performance in a sow-piglet model by mother-infant microbiota transmission and placental mTOR signaling. World J Microbiol Biotechnol. 2024;41:13. doi:10.1007/s11274-024-04222-5
- Mirsalami SM, Mirsalami M. Leveraging Lactobacillus plantarum probiotics to mitigate diarrhea and Salmonella infections in broiler chickens. AMB Express. 2024;14:137. doi:10.1186/s13568-024-01792-3
- Shah SA, Naz S, Jabeen F, Rashid MA, Rahman A, et al. COMPARISON OF BACTERIAL PROBIOTICS (BIFIDOBACTERIUM AND LACTOBACILLUS) VERSUS FUNGAL PROBIOTICS (SACCHAROMYCES) IN THE TREATMENT OF ACUTE DIARRHOEA IN CHILDREN AGED 6 MONTHS TO 5 YEARS. J Ayub Med Coll Abbottabad. 2024;36:537. doi:10.55519/JAMC-03-13464
- Chen K, Zeng K, Jin S, Ma Y, Cai L, et al. LRa05 in the treatment of acute diarrhea in children: a randomized controlled trial. Front Nutr. 2024;11:1479186. doi:10.3389/fnut.2024.1479186
- Shin I, Kang Y, Ahn J, Kim Y, Nam J, et al. The potential probiotic role of Lacticaseibacillus rhamnosus on growth performance, gut health, and immune responses of weaned pigs. J Anim Sci. 2025. doi:10.1093/jas/skaf089
- Chen K, Zeng K, Jin S, Ma Y, Cai L, et al. LRa05 in the treatment of acute diarrhea in children: a randomized controlled trial. Front Nutr. 2024;11:1479186. doi:10.3389/fnut.2024.1479186
- Gwee KA, Lee WRW, Chua Q, Chiou FK, Aw MM, et al. The evidence for probiotics in the treatment of digestive disorders in the pediatric population. J Gastroenterol Hepatol. 2025;40:41. doi:10.1111/jgh.16809
- Shah J, Adnan SH, Yousaf MS, Din SJU, Haq MU, et al. A Multi-Hospital Comparative Study on the Efficacy of Probiotics Versus Placebo in Preventing Antibiotic-Associated Diarrhea in Adult Patients. Cureus. 2024;16:e70881. doi:10.7759/cureus.70881
- Shawky LM, Abo El Wafa SM, Behery M, Bahr MH, Abu Alnasr MT, et al. Lactobacillus rhamnosus GG and Tannic Acid Synergistically Promote the Gut Barrier Integrity in a Rat Model of Experimental Diarrhea via Selective Immunomodulatory Cytokine Targeting. Mol Nutr Food Res. 2024;68:e2400295. doi:10.1002/mnfr.202400295
- Anvarifard P, Anbari M, Ghalichi F, Ghoreishi Z, Zarezadeh M. The effectiveness of probiotics as an adjunct therapy in patients under mechanical ventilation: an umbrella systematic review and meta-analysis. Food Funct. 2024;15:5737. doi:10.1039/d3fo04653b
- Alharbi BF, Alateek AA. Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review. Travel Med Infect Dis. 2024;59:102703. doi:10.1016/j.tmaid.2024.102703
- Abdulah DM, Sulaiman SJ, Ahmed ZW. Effect of probiotics plus zinc supplementation on clinical outcomes of infants and children with acute infectious diarrhea: a randomized controlled trial. Clin Exp Pediatr. 2024;67:203. doi:10.3345/cep.2023.01340
- Waitzberg D, Guarner F, Hojsak I, Ianiro G, Polk DB, et al. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?. Adv Ther. 2024;41:901. doi:10.1007/s12325-024-02783-3
- Saviano A, Petruzziello C, Cancro C, Macerola N, Petti A, et al. The Efficacy of a Mix of Probiotics ( LMG P-27481 and GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial. Microorganisms. 2024;12. doi:10.3390/microorganisms12010198
- Poeta M, Cioffi V, Tarallo A, Damiano C, Lo Vecchio A, et al. Postbiotic Preparation of against Diarrhea and Oxidative Stress Induced by Spike Protein of SARS-CoV-2 in Human Enterocytes. Antioxidants (Basel). 2023;12. doi:10.3390/antiox12101878
- Drozdov VN, Shikh EV, Astapovskii AA, Khalaidzheva KN, Solovieva SA, et al. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea]. Vopr Pitan. 2023;92:92. doi:10.33029/0042-8833-2023-92-4-92-103
- Mego M, Danis R, Chovanec J, Jurisova S, Bystricky B, et al. Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12 LGG in colorectal cancer patients. Front Oncol. 2023;13:1168654. doi:10.3389/fonc.2023.1168654
- Yang Q, Hu Z, Lei Y, Li X, Xu C, et al. Overview of systematic reviews of probiotics in the prevention and treatment of antibiotic-associated diarrhea in children. Front Pharmacol. 2023;14:1153070. doi:10.3389/fphar.2023.1153070
- Niu H, Zhou X, Liu P, Wu Y, Lyu L, et al. Lactobacillus rhamnosus MN-431 Metabolic Tryptophan Alleviates Complementary Food-Induced Diarrhea through PXR-NF-κB Pathway and AHR-Th17 Cell Response Pathways. Mol Nutr Food Res. 2023;67:e2200530. doi:10.1002/mnfr.202200530
- Li J, Li Q, Wu Q, Gao N, Wang Z, et al. Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway. J Anim Sci Biotechnol. 2023;14:23. doi:10.1186/s40104-023-00830-7
